P-025 Synergistic antitumor activity of the BCMA 2+1 T-cell engager (TCE) alnuctamab (ALNUC; BMS-986349; CC-93269) and CELMoD agents in multiple myeloma (MM) preclinical models

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 23; pp. S46 - S47
Main Authors Paiva, Bruno, Gaffney, Bonny, Burnett, Kelven, Castiglioni, Paola, La Motte-Mohs, Ross, Angelo, Michael, Pierce, Daniel, Boss, Isaac
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2023
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)01643-9